

Vaccine Makers Curtail Research and Cut Jobs
Continue reading at The New York Times


BILL Stock Down 24%, Core Revenue Up 17%: Why a 14% Portfolio Bet Signals Conviction
Continue reading at Nasdaq


Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake
Continue reading at Nasdaq


3 Dirt Cheap Stocks to Buy With $1,000 Right Now
Continue reading at Nasdaq


Macquarie-Led Consortium To Acquire Qube In $11.7 Bln Deal
Continue reading at Nasdaq


Up 50% in One Year: Why a Fund Cut $5 Million in TriMas Stock but Held Onto a 3% Position
Continue reading at Nasdaq


Intel Stock Has Gotten Way Ahead of Lip-Bu Tan's Turnaround Plans. Will Investors Regret Buying?
Continue reading at Nasdaq


Real Estate Rebound? The 3X Play for Investors Betting on a Commercial Property Pivot
Continue reading at Nasdaq


Small Cap ETFs: VB Boasts Lower Fees, While ISCB Sports a Higher Dividend Yield
Continue reading at Nasdaq


Americold Stock Down 40% This Past Year, so Why Did One Fund Just Invest $3 Million?
Continue reading at Nasdaq


Still Working at 65? This Medicare Mistake Could Cost You for Life.
Continue reading at Nasdaq


Chou Associates Dumps 293,000 Shares of This Berkshire Hathaway Holding
Continue reading at Nasdaq